Teraoka H, Tsukada K
Biochim Biophys Acta. 1986 Sep 26;873(2):297-303. doi: 10.1016/0167-4838(86)90057-9.
Using specific antibodies against calf thymus DNA ligases I and II (EC 6.5.1.1), we have investigated the polypeptide structures of DNA ligases I and II present in the impure enzyme preparations, and estimated the polypeptides of DNA ligases I and II present in vivo. Immunoblot analysis of DNA ligase I after sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a 130-kDa polypeptide as a major one in the enzyme preparations from calf thymus throughout the purification. In addition to the 130-kDa polypeptide, a 200-kDa polypeptide was detected in the enzyme preparations at the earlier steps of the purification, and a 90-kDa polypeptide was observed as a minor one in the enzyme preparations at the later steps of the purification. The polypeptides with molecular weight of 130 000 and 90 000 were detected by SDS-polyacrylamide gel electrophoresis of DNA ligase I-[3H]AMP complex. These results suggest that a 200-kDa polypeptide of DNA ligase I present in vivo is degraded to a 130-kDa polypeptide and then to a 90-kDa polypeptide during the isolation and purification procedures. On the other hand, the monospecific antibody against calf thymus DNA ligase II cross-reacted with only a 68 kDa polypeptide in the enzyme preparations throughout the purification, suggesting that the 68-kDa polypeptide is a single form of calf thymus DNA ligase II present in vivo as well as in vitro.
利用针对小牛胸腺DNA连接酶I和II(EC 6.5.1.1)的特异性抗体,我们研究了不纯酶制剂中存在的DNA连接酶I和II的多肽结构,并估算了体内存在的DNA连接酶I和II的多肽。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳后对DNA连接酶I进行免疫印迹分析显示,在小牛胸腺酶制剂的整个纯化过程中,一条130 kDa的多肽是主要的。除了130 kDa的多肽外,在纯化早期步骤的酶制剂中检测到一条200 kDa的多肽,在纯化后期步骤的酶制剂中观察到一条90 kDa的多肽为次要成分。通过对DNA连接酶I-[3H]AMP复合物进行SDS-聚丙烯酰胺凝胶电泳检测到分子量为130 000和90 000的多肽。这些结果表明,体内存在的DNA连接酶I的200 kDa多肽在分离和纯化过程中降解为130 kDa多肽,然后再降解为90 kDa多肽。另一方面,针对小牛胸腺DNA连接酶II的单特异性抗体在整个纯化过程中仅与酶制剂中的一条68 kDa多肽发生交叉反应,这表明68 kDa多肽是小牛胸腺DNA连接酶II在体内和体外存在的单一形式。